Endocrine Abstracts

Lithium-induced hyperparathyroidism was first described in 1973 by Garfinkel et. al.The two cases aim to illustrate Lithium-induced hyperparathyroidism which was previously thought to be a rare occurrence and outline characteristic features of this disorder.Case 1.A 51 year old male presented with polydipsia and polyuria. He was known to suffer from bipolar affective disorder with lithium treatment was admitt...

Background:TAO is a progressive autoimmune potentially sight-threating disease. Various medical interventions have been reported which have potencially serious side effects.The high-dose intravenous immunoglobulin (IVIG) is known to have anti-inflammatory potential and it was used in pilot studies for patients with TAO. The aim of study : was to investigate the effect of IVIG on post-partum relapsed TAO and to test the some immunological parameters during and after therapy. Pa...

Lithium-induced hyperparathyroidism was first described in 1973 by Garfinkel et. al.The two cases aim to illustrate Lithium-induced hyperparathyroidism which was previously thought to be a rare occurrence and outline characteristic features of this disorder.Case 1.A 51 year old male presented with polydipsia and polyuria. He was known to suffer from bipolar affective disorder with lithium treatment was admitt...